| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDT | Ordinary Shares | Award | $0 | +832 | +1.87% | $0.00 | 45.4K | Nov 1, 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDT | Stock Option (Right to Buy) | Award | $0 | +6.67K | $0.00 | 6.67K | Nov 1, 2021 | Ordinary Shares | 6.67K | $120.23 | Direct | F3 | |
| transaction | MDT | Performance Share Units | Award | $0 | +2.08K | $0.00 | 2.08K | Nov 1, 2021 | Performance Share Units | 2.08K | Direct | F4, F5, F6 |
| Id | Content |
|---|---|
| F1 | The restrictions on the award shall lapse 100% on August 2, 2024. |
| F2 | This balance increased by 97 shares due to exempt transactions such as dividend reinvestment. |
| F3 | These options become exercisable at the rate of 25% of the shares granted per year beginning on the date noted. |
| F4 | Each performance share unit represents a contingent right to receive one share of Medtronic common stock. |
| F5 | The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 2,080 shares will be issued. The actual number of shares to be issued could range from a low of 0 shares at minimum performance to a high of 4,160 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. |
| F6 | Vests on August 2, 2024. |